Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the “Company” or “Sona”) is pleased to advise that it has appointed Dr. Carman Giacomantonio MD, MSc., FRCSC (Cav.) to be the Company’s Chief Medical Officer. Dr. Giacomantonio is a practicing Surgical Oncologist at the QEII Health Sciences Centre and a Professor of Surgery at Dalhousie University. Dr. Giacomantonio leads a productive translational research group at Dalhousie University and has successfully initiated two clinical trials in cancer immunotherapy. He is widely published in the field of cancer immunobiology and immunotherapy research, and a recognized innovator in the field of intra-tumoral cancer immunotherapy. Dr. Giacomantonio currently serves on Sona’s Advisory Board and is the Principal Investigator for Sona’s pre-clinical studies using Sona’s gold nanorods in its Targeted Hyperthermia Therapy (“THT”) for triple negative breast cancer, melanoma, and colorectal cancer. Sona is extremely excited to have Dr. Giacomantonio’s vision and experience to lead the development of our THT-based immunotherapy towards first-in-human clinical trials.
Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company” or “Sona”) announces that it has been approved for funding totaling approximately $40,000 to support the development of its intellectual property portfolio.
The Company is receiving advisory services and up to $24,894 in funding from the National Research Council of Canada Industrial Research Assistance Program (“NRC IRAP”) IP Assist program to support the development of an intellectual property strategy for Sona’s proprietary gold nanorods for novel targeted drug delivery concepts with a view to securing new patents.
Halifax, Nova Scotia-(Newsfile Corp. – April 26, 2024) – E-Tech Resources Inc. (TSXV: REE) (FSE: K2I) (“E-Tech” or the “Company“) is pleased to announce the appointment of Christopher Drysdale as interim Chief Executive Officer (“CEO”) of the Company. Mr. Drysdale is an experienced professional with international experience in the mineral and exploration industry. Currently serving as the […]
Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company” or “Sona”) is pleased to announce further positive interim results from its study with The Giacomantonio Immuno-Oncology Research Group at Dalhousie University (the “Study”).
Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company” or “Sona”) announces that it has been approved for funding totaling approximately $40,000 to support the development of its intellectual property portfolio.
The Company is receiving advisory services and up to $24,894 in funding from the National Research Council of Canada Industrial Research Assistance Program (“NRC IRAP”) IP Assist program to support the development of an intellectual property strategy for Sona’s proprietary gold nanorods for novel targeted drug delivery concepts with a view to securing new patents.
Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company” or “Sona”) announces positive interim results from its study with The Giacomantonio Immuno-Oncology Research Group at Dalhousie University (the “Study”). An update received by the Company indicates that all tumors treated within the Study to date with a single Targeted Hyperthermia Therapy (“THT”) treatment shrunk within the first 24 hours, with an average reduction in size of 80% compared to matched controls.
Halifax, Nova Scotia – (Newsfile Corp. – March 21, 2024) – Torrent Capital Ltd. (TSXV:TORR) (“Torrent Capital”) congratulates Port of Argentia and Hamburg Port Authority on the signing of a Letter of Intent (“LOI”) to collaborate on the export and import of green hydrogen from Canada to Germany. The agreement was signed in Hamburg during the […]
Halifax, Nova Scotia – (Newsfile Corp. March 21, 2024) – E-Tech Resources Inc. (TSXV: REE) (FSE: K2i) (“E-Tech” or the “Company”) is pleased to announce the successful completion of its trenching and sampling program at the Eureka project in Namibia. The program revealed significant rare earth oxide mineralization across multiple locations within Exclusive Prospecting License (“EPL”) […]
Antler Gold Inc. (“Antler” or “Company”) (TSX-V:ANTL) is pleased to announce the expansion of its land holding in Namibia. Two additional exploration licenses have been awarded to Antler by the Ministry of Mines and Energy of Namibia, pending issuance of environmental clearance, as well as the renewal of Exclusive Prospecting Licenses EPL-8010 and EPL-6408 (Erongo Central Gold Project).
Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company” or “Sona”) announces that it has submitted a provisional patent application with the United States Patent and Trademark Office (USPTO), for its proprietary photothermal light device, entitled, “ENDOSCOPE WITH EMR OPTICAL FIBER AND THERMAL SENSOR FOR PHOTOTHERMAL THERAPY”.